Abstract P4-01-21: Phase 2 Study of the CDK4/6 Inhibitor FCN-437c in Combination with Fulvestrant or Letrozole and Goserelin in Patients with HR+, HER2– Advanced Breast Cancer
Cancer Research(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Cancer Research(2023)